BECN1 and renal cell carcinoma: A poorer prognosis of patients expressing low Beclin 1 levels has also been reported in multiple tumor entities, such as breast [30,42], ovarian [32,33], oral [43], gastric [39,40], and renal cell carcinoma [41].